In the attached report average Valuation for Phase 3 biotech companies on the asx is $405 mill and Phase 2 are valued at $80 mill ,go to page 34 to see the table .We have 3 Phase 2 possibilities .Possible Valuation $645 mill and we are currently valued on the asx at $150 mill .The current valuation is certainly out of whack .
https://www2.asx.com.au/content/dam/asx/documents/listings/AusBiotech-Guide-to-Life-Sciences-Investing-web-version.pdf
- Forums
- ASX - By Stock
- NEU
- Valuations
Valuations
-
- There are more pages in this discussion • 60 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 249 | $20.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.31 | 790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 249 | 20.150 |
5 | 650 | 20.000 |
3 | 776 | 19.900 |
6 | 2760 | 19.800 |
1 | 400 | 19.780 |
Price($) | Vol. | No. |
---|---|---|
20.680 | 888 | 1 |
20.800 | 500 | 1 |
20.900 | 500 | 1 |
21.000 | 2200 | 3 |
21.200 | 611 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |